Pnc Financial Services Group, Inc. Oncocyte Corp Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$1.15 - $2.25 $11,500 - $22,500	10,000 New	10,000 $14,000
Q4 2021 Feb 11, 2022	SELL	$2.04 - $3.59 $616 - $1,084	-302 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$3.53 - $5.89 $1,066 - $1,778	302 New	302 $1,000
Q3 2020 Nov 06, 2020	SELL	$1.2 - $1.89 $16 - $26	-14 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$4.55 - $7.55 $63 - $105	14	14 $0

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.